Aerie Pharmaceuticals Inc
AERI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$729.25M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $729.25 Million |
|---|---|
| Enterprise Value | $869.38 Million |
| Earnings per Share | $-1.61 |
| Beta | -0.06 |
| Outstanding Shares | 47,819,936 |
Return
| Return on Equity | 22.29% |
|---|---|
| Return on Assets | -9.73% |
| Return on Invested Capital | -11.03% |
Valuation & Multiples
| P/E Ratio | -9.47 |
|---|---|
| PEG | 29.22 |
| Price to Sales | 3.81 |
| Price to Book Ratio | -3.81 |
| Enterprise Value to Revenue | 4.06 |
| Enterprise Value to EBIT | -32.55 |
| Enterprise Value to Net Income | -24 |
| Total Debt to Enterprise | 0.36 |
| Debt to Equity | -1.91 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Aerie Pharmaceuticals Inc
CEO: Vicente Anido
